Open AccessClinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis
Author(s) -
Santiago A. LozanoCalderón,
Cassandra Garbutt,
Jason Kim,
Christopher B. Lietz,
YenLin Chen,
Karen De Amorim Bernstein,
Ivan Chebib,
G. Petur Nielsen,
Vikram Deshpande,
Renee Rubio,
Yaoyu E. Wang,
John Quackenbush,
Thomas F. DeLaney,
Kevin A. Raskin,
Joseph H. Schwab,
Gregory M. Coté,
Dimitrios Spentzos
Publication year - 2019
Publication title -
clinical orthopaedics and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.178
H-Index - 204
eISSN - 1528-1132
pISSN - 0009-921X
DOI - 10.1097/corr.0000000000000867
Subject(s) - osteosarcoma , medicine , microrna , metastasis , disease , oncology , chemotherapy , pathology , cancer , gene , biochemistry , chemistry
MicroRNAs are small, noncoding RNAs that regulate the expression of posttranslational genes. The presence of some specific microRNAs has been associated with increased risk of both local recurrence and metastasis and worse survival in patients with osteosarcoma. Pathologic fractures in osteosarcoma are considered to be more the manifestation of a neoplasm with a more aggressive biological behavior than the cause itself of worse prognosis. However, this has not been proved at the biological or molecular level. Currently, there has not been a microRNA profiling study of patients who have osteosarcoma with and without pathologic fractures that has described differences in terms of microRNA profiling between these two groups and their correlation with biologic behavior.